FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Lonza Swiss Facility Gets FDA-483

[ Price : $8.95]

FDA issues a one-item 483 after inspecting a Lonza Visp, Switzerland manufacturing facility.

Gene Therapy Interactive Site Tours Program

[ Price : $8.95]

Federal Register notice: FDA announces the Cellular and Gene Therapies Interactive Site Tours Program that is intended to give CBE...

Fast Track Awarded to Leukemia Drug

[ Price : $8.95]

FDA grants Sumitomo Pharma America a fast track designation for DSP-5336 and its use in treating certain patients with relapsed or...

FDA Withdraws Takeda NDA for Exkivity

[ Price : $8.95]

Federal Register notice: FDA withdraws approval of a Takeda NDA for Exkivity (mobocertinib succinate) capsules after a confirmator...

AskBio Gets Fast Track for Parkinsons Gene Therapy

[ Price : $8.95]

FDA grants Bayer-owned Asklepios BioPharmaceutical a fast track designation for AB-1005, a gene therapy candidate for treating mod...

2 Updated Guides on Dental Resin and Curing Lights

[ Price : $8.95]

Federal Register notice: FDA releases two draft guidances entitled Dental Composite Resin Devices Premarket Notification (510(k))...

Oticon Sentio Hearing Device Cleared

[ Price : $8.95]

FDA clears an Oticon Medical 510(k) for its active transcutaneous bone conduction hearing system, the Sentio System.

Rinvoq sNDA for Giant Cell Arteritis Filed

[ Price : $8.95]

AbbVie submits a supplemental NDA for Rinvoq and its use in treating adult patients with giant cell arteritis.

Gottlieb Calls for Congress Help with AI Device Regulation

[ Price : $8.95]

Former FDA commissioner Scott Gottlieb says Congress needs to design a framework for the modern, efficient regulation of medical a...

Indivior Pulls Plug on Schizophrenia Drug Marketing

[ Price : $8.95]

Citing payor management concerns, Indivior says it is discontinuing sales and marketing for schizophrenia drug Perseris (risperido...